Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suzan Cinar"'
Autor:
Metin Yusuf Gelmez, Fatma Betul Oktelik, Suzan Cinar, Murat Ozbalak, Ozden Ozluk, Melih Aktan, Gunnur Deniz
Publikováno v:
Journal of Hematopathology. 15:117-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c843cbdb5030cc514f46612e50b722
https://doi.org/10.1007/s12308-022-00497-5
https://doi.org/10.1007/s12308-022-00497-5
Autor:
Safak Mirioglu, Suzan Cinar, Omer Uludag, Erdem Gurel, Sibel Varelci, Yasemin Ozluk, Isin Kilicaslan, Yasemin Yalcinkaya, Halil Yazici, Ahmet Gul, Murat Inanc, Bahar Artim-Esen
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Galectin-9, interferon-inducible protein-10 (IP-10) and sialoadhesin (SIGLEC-1) are considered as potential biomarkers reflecting disease activity in patients with systemic lupus erythematosus (SLE). In this study, we aimed to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::940991a751d2c894a9ce0c9385b66f08
https://doi.org/10.1093/ndt/gfac110.003
https://doi.org/10.1093/ndt/gfac110.003
Autor:
Selma Sari, Suzan Cinar, Yasemin Yalcinkaya, Bahar Artim-Esen, Yasemin Ozluk, Ahmet Gul, Lale Ocal, Günnur Deniz, Murat Inanc
Publikováno v:
Lupus. 31(5)
Objectives We aim to investigate the association between serum B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL) levels with disease activity and clinical findings in SLE patients. Methods Seventy-nine patients with SLE and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185fa9e4dba28823340cab36b251f439
https://pubmed.ncbi.nlm.nih.gov/35249405
https://pubmed.ncbi.nlm.nih.gov/35249405
Publikováno v:
Turkish Journal of Immunology. 1:63-67
©2013 Turkish Journal of Immunology. All rights reserved. Amac: Bu calismada, tolerans kirici molekullerin bir immunoterapi modelinde sinanmasi amaclandi. Hastalar ve yontemler: Bu calismaya basarili subkutan immunoterapi almis astim hastalari (n=3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b0a80b839ec104590d556677cc7bdd8
https://doi.org/10.5606/tji.2013.283
https://doi.org/10.5606/tji.2013.283
Publikováno v:
Bezmiâlem Science, Vol 10, Iss 6, Pp 691-697 (2022)
Objective:Acute lymphoblastic leukemia (ALL) is the most prevalent type of cancer in children. Minimal residual disease (MRD) is still the most important indicator of clinical results and relapse after chemotherapy. Multidrug resistance is the main o
Externí odkaz:
https://doaj.org/article/59cb805163264ea4a1b823eb4256d861
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 3, Pp 202-208 (2016)
Objective: Chronic lymphocytic leukemia (CLL) is a disease that shows varying clinical progression, and expression of the protein tyrosine kinase ZAP70 has been described as a very valuable prognostic factor. Patients with ZAP70 positivity are charac
Externí odkaz:
https://doaj.org/article/33667219e5a2477e8da6f2adf72c58cf
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Cyclooxygenase (COX) inhibitors, already widely used for the treatment of pain and inflammation, are considered as promising compounds for the prevention and treatment of neoplasia. The aim of our study was to determine the direct antiproliferative e
Externí odkaz:
https://doaj.org/article/7fd1b81f1c804e1580b4ed4a002d38e8